coagulation factor

Also found in: Thesaurus, Medical, Legal, Financial, Encyclopedia, Wikipedia.

coagulation factor

(Biochemistry) med another name for clotting factor

ThesaurusAntonymsRelated WordsSynonymsLegend:

Switch to new thesaurus

Noun

coagulation factor - any of the factors in the blood whose actions are essential for blood coagulation

clotting factor

plasma protein - any of the proteins in blood plasma

factor I, fibrinogen - a protein present in blood plasma; converts to fibrin when blood clots

factor II, prothrombin - a protein in blood plasma that is the inactive precursor of thrombin

factor III, thrombokinase, thromboplastin - an enzyme liberated from blood platelets that converts prothrombin into thrombin as blood starts to clot

calcium ion, factor IV - ion of calcium; a factor in the clotting of blood

accelerator factor, factor V, proaccelerin, prothrombin accelerator - a coagulation factor

cothromboplastin, factor VII, proconvertin, stable factor - a coagulation factor formed in the kidney under the influence of vitamin K

antihaemophilic factor, antihaemophilic globulin, antihemophilic factor, antihemophilic globulin, factor VIII, Hemofil - a coagulation factor (trade name Hemofil) whose absence is associated with hemophilia A

Christmas factor, factor IX - coagulation factor whose absence is associated with hemophilia B

factor X, prothrombinase - coagulation factor that is converted to an enzyme that converts prothrombin to thrombin in a reaction that depends on calcium ions and other coagulation factors

factor XI, plasma thromboplastin antecedent - coagulation factor whose deficiency results in a hemorrhagic tendency

factor XII, Hageman factor - coagulation factor whose deficiency results in prolongation of clotting time of venous blood

factor XIII, fibrinase - in the clotting of blood thrombin catalyzes factor XIII into its active form (fibrinase) which causes fibrin to form a stable clot

References in periodicals archive ?

The Blood Coagulation Factor balance in healthcare organizations was 118,250 IU at the end of 2017.

114 children suffer from hemophilia in Kyrgyzstan

Acquired coagulation factor V (FV) inhibitors are rare and their presentations varied.

Factor V Inhibitors: A Diagnostic and Therapeutic Challenge

Visit Hemophilia Treatment Market by Drug Type (Antifibrinolytic Agents, Desmopressin, Plasma Derived Coagulation Factor Concentrates - Factor VIII, Factor IX, Combination, Recombinant Coagulation Factor Concentrates - Factor VIII, Factor IX, Combination), Indication Type (Acquired Hemophilia, Hemophilia A, Hemophilia B, Hemophilia C), and Distribution Channel (E-commerce, Hospital Pharmacies, Retail Pharmacies) and Forecast 2017-2021 at https://www.

Hemophilia Treatment Market by Drugs, Distribution Channels, Trends and Forecast to 2021, Upcoming Research by iHealthcareAnalyst, Inc.

In the initiation phase, which is the first phase, coagulation starts when the vasculature is injured and subendothelial cells expose tissue factor (TF), which is the key initiator of haemostasis, that binds to coagulation factor VII, leading to its activation to FVIIa.

The Complex Process of Haemostasis and Interactions due to Hyperosmotic Fluids/Kompleks Hemostaz Sureci ve Hiperozmotik Sivilardan Kaynaklanan Etkilesimler

Objective: To provide a comprehensive literature review on roles of coagulation factor XIII (FXIII) in coagulation, wound healing, neoplasm, bone metabolism, and pregnancy.

Advances of Coagulation Factor XIII

Hemoglobin and platelet count were within reference intervals, and coagulation testing showed markedly prolonged clotting times and multiple coagulation factor deficiencies (Table 1).

Sudden Severe Bleeding in a Patient with Hemochromatosis: Liver Failure or Something Else?

CSL Behring received approval from the FDA for IDELVION [Coagulation Factor IX (Recombinant), Albumin Fusion Protein], its novel, long-acting albumin fusion protein linking recombinant coagulation factor IX with recombinant albumin for the treatment of hemophilia B.

Genentech, a member of the Roche Group, received approval from the FDA for Gazyva (obinutuzumab) plus bendamustine chemotherapy followed by Gazyva alone as a new treatment for people with follicular lymphoma who did not respond to a Rituxan (rituximab) regimen

Biopharmaceutical company Baxalta (NYSE:BXLT) reported on Thursday the receipt of approval for Health Canada's OBIZUR for the treatment of bleeding episodes in patients with acquired hemophilia A caused by autoantibodies to coagulation Factor VIII (FVIII).

Baxalta passes Health Canada's approval for OBIZUR for Acquired Hemophilia A

There is no drug or diet supplement that can supply the missing coagulation factor in pets with hemophilia.

Life-saving screening for hemophilia: specialized testing at Cornell's Coagulation Lab permits earlier diagnosis and treatment of the bleeding disorder

Conclusion: Coagulation factor deficiencies, with factor VIII deficiency being the commonest are the most frequent bleeding disorders.

FREQUENCY OF BLEEDING DISORDERS DIAGNOSED AT ARMED FORCES INSTITUTE OF PATHOLOGY RAWALPINDI

The coagulation factor IX precursor contains coagulation factor IXa light chain and heavy chain.

Descriptively probabilistic relationship between mutated primary structure of coagulation factor IX and clinical severity of hemophilia B

Once in the liver, these cells would form small colonies capable of producing the missing coagulation factor.